ERBI unveils new name and brand identity: One Nucleus
ERBI, the not-for-profit membership company for international life science and healthcare businesses, unveiled its new name and brand identity – One Nucleus – at the opening of its 12th annual Conference at the Wellcome Trust Sanger Institute, Cambridge, UK.
One Nucleus is a new name for a new era, representing one network for biotech, pharma, medical device and diagnostic businesses. One Nucleus also speaks to the unification of the Cambridge and London Networks, following ERBI’s merger with the London Biotechnology Network (LBN).
One Nucleus CEO, Harriet Fear, commented: “One Nucleus is the business catalyst for life sciences. We’d outgrown ERBI and needed a new name to match our reality as a global force in life science and healthcare. We intend to use this new identity as a springboard to new and improved benefits for members, building on the combined strength of our Cambridge and London membership.”
Other news from the department business & finance
